In the case of lung cancer, some studies have previously reported that SOX2‐OT overexpression is associated with worse clinical outcomes, suggesting a role as an independent prognostic factor, though the data remain inconclusive thus far [22, 32]. This evidence concerns the gene OXT and lung carcinoma.